INDIGO Press Releases

Catch up on the latest news and announcements from INDIGO Biosciences.

INDIGO Biosciences Introduces Cell-Based Luciferase Reporter Assay for Hepatocyte Nuclear Factor 4 Alpha (HNF4α)

Nuclear Receptors and Cancer Research: Current Trends and Applications A New Sensitive, Time-Saving Assay for Preclinical Research of Metabolic Regulation and Disease Pathogenesis. State College, PA (20 April 2024) – INDIGO Biosciences, a leading provider of innovative cell-based reporter assays, announced today the launch of its latest Nuclear Receptor Assay: the Human Hepatocyte Nuclear Factor…

INDIGO Biosciences Releases Cell-Based Luciferase Reporter Assay for the Human Oxytocin Receptor

INDIGO’s New Assay for Preclinical Research of Cancer and Autoimmune Diseases GM-CSFR. State College, PA (20 March 2024) – INDIGO Biosciences, a leading provider of innovative cell-based reporter assays, announced today the launch of its latest G-Protein Coupled Receptor assay: the Human Oxytocin Receptor (OXTR) Reporter Assay. “INDIGO is pleased to introduce this robust assay,”…

INDIGO Biosciences Releases a Family of Cell-Based Reporter Assays for the Adrenergic Receptors

A New Family of Assays Including ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 for Preclinical Research of Heart Failure, Hypertension, Obesity, and Respiratory Conditions State College, PA (February 21th, 2024) – INDIGO Biosciences announced today the release of new cell-based reporter assays for the family of Human Adrenergic Receptors, including ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2. “INDIGO is…

INDIGO Biosciences Releases a Family of Cell-Based Reporter Assays for the Colony Stimulating Factor Receptors G-CSFR, M-CSFR, & GM-CSFR

A New Family of Assays for Preclinical Research of Cancer, Inflammation & Autoimmune Disorders State College, PA (17 January 2024) – INDIGO Biosciences announced today the release of new cell-based reporter assays for the family of Human Colony-Stimulating Factor Receptors: Granulocyte Colony-Stimulating Factor Receptor (G-CSFR), Macrophage Colony-Stimulating Factor Receptor (M-CSFR), and Granulocyte Macrophage Colony-Stimulating Factor…

INDIGO Biosciences Wraps Up 2023 with a Record Number of New Product Releases

New Cell-Based Reporter Assays Included Those for Nuclear Receptors, GPCRs, and Growth Factors State College, PA (January 12th, 2024) – INDIGO Biosciences concluded 2023 with a record number of new product releases, adding 17 new assays to its portfolio of cell-based reporter gene assays targeting Nuclear Receptors, G-protein Coupled Receptors (CPCRs), Growth Factors, Transcription Factors,…

INDIGO Biosciences Releases Cell-Based Luciferase Reporter Assay for the Human Glucagon-Like Peptide-1 Receptor (GLP-1R)

A New Assay for Preclinical Research of Type II Diabetes and Obesity State College, PA (20 November 2023) – INDIGO Biosciences announced today the release of a new cell-based reporter assay for the Human Glucagon-Like Peptide-1 Receptor (GLP-1R), a member of the G protein-coupled receptor (GPCR) family. “A reliable GLP-1R assay is essential for researchers…

INDIGO Biosciences Releases Cell-Based Luciferase Assay for the Human Adrenoreceptor Alpha 1A (ADRA1A)

A New Assay for Preclinical Research of Neurological Disease, Cardiovascular Disease, and Diabetes. State College, PA  – September 25th, 2023 INDIGO Biosciences announced today the release of a new cell-based reporter assay for the Human Adrenoreceptor Alpha 1A (ADRA1A), a member of the G protein-coupled receptor (GPCR) family. “Since ADRA1A has the potential to be…

New Assay Cell-Based Luciferase Reporter Assay developed for GM-CSFR

INDIGO’s New Assay for Preclinical Research of Cancer and Autoimmune Diseases GM-CSFR. State College, PA (June 27th, 2023) – Today INDIGO Biosciences announced the release of a new cell-based reporter assay for Granulocyte-Macrophage Colony-Stimulating Factor Receptor (GM-CSFR or CSF2R). This new commercially available all-inclusive assay kit from INDIGO can help preclinical researchers get the data…

New Environmental Monitoring and Toxicology Assays

INDIGO’s New Family of Assays for Environmental Monitoring and Toxicology Provide a Screening Tool for Endocrine Disrupting Chemicals. State College, PA (May 18, 2023) – Today INDIGO Biosciences released a new family of cell-based luciferase reporter assays specifically developed for use in environmental testing applications such as screening samples for endocrine disrupting chemicals. The assays…

INDIGO Biosciences Releases Reporter Assays for Insulin Receptor and Insulin-like Growth Factor 1 Receptor

Two New Assays for Preclinical Research of Cancer, Diabetes, and Cardiovascular Disease State College, PA (17 April 2023) – INDIGO Biosciences announced today the release of two new cell-based reporter assays for the Insulin Receptor, isoform B (INSRb) and Insulin-like Growth Factor 1 Receptor (IGF-1R), both members of the receptor tyrosine kinase (RTK) family. “These…